Teva to Cut 5,000 Jobs to Speed Up $2 Billion in Savings

Teva Pharmaceutical Industries Ltd., the world’s largest maker of generic drugs, plans to eliminate about 5,000 jobs as it accelerates cost reductions amid growing competition for the company’s best-selling product.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.